Schrodinger
ISIN US80810D1037
|WKN A2PY7M
Overview
Quote
GBP 18.68
11/04/2025 (gettex)
+8.98%
daily change
52 weeks low/high
13.01
21.26
Description
Schrödinger, Inc. levert softwareoplossingen voor chemische simulatie aan de farmaceutische industrie. Het is actief via de bedrijfssegmenten Software en Drug Discovery. Het Software segment verkoopt software om de ontdekking van medicijnen te transformeren in de biowetenschappen industrie en aan klanten in de materiaalwetenschappen industrie. Het Drug Discovery segment biedt een gevarieerde portefeuille van preklinische en klinische programma's, intern en via samenwerkingsverbanden, die zich in verschillende stadia van ontdekking en ontwikkeling bevinden. Het bedrijf werd in 1990 opgericht door Richard A. Friesner, William A. Goddard, III en Murco Ringnalda en het hoofdkantoor is gevestigd in New York, NY.
Gezondheidszorg Gezondheidszorg Diensten Ondersteuningsdiensten voor de Gezondheidszorg Verenigde Staten
Financials
Key metrics
Market capitalisation, EUR | 1.255,58 m |
EPS, EUR | -2,38 |
P/B ratio | 3,32 |
P/E ratio | 46,52 |
Dividend yield | 0,00% |
Income statement (2024)
Revenue, EUR | 191,86 m |
Net income, EUR | -172,99 m |
Profit margin | -90,16% |
What ETF is Schrodinger in?
There are 26 ETFs which contain Schrodinger. All of these ETFs are listed in the table below. The ETF with the largest weighting of Schrodinger is the ARK Genomic Revolution UCITS ETF USD Accumulating.
Performance
Returns overview
YTD | +20.28% |
1 month | +11.32% |
3 months | +18.15% |
6 months | +38.17% |
1 year | -14.39% |
3 years | - |
5 years | - |
Since inception (MAX) | -52.41% |
2024 | -46.63% |
2023 | - |
2022 | - |
2021 | - |
Monthly returns in a heat map
Risk
Risk metrics in this section:
- Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
- Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
- Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.
Risk overview
Volatility 1 year | 57.69% |
Volatility 3 years | - |
Volatility 5 years | - |
Return per risk 1 year | -0.25 |
Return per risk 3 years | - |
Return per risk 5 years | - |
Maximum drawdown 1 year | -40.38% |
Maximum drawdown 3 years | - |
Maximum drawdown 5 years | - |
Maximum drawdown since inception | -69.90% |
Rolling 1 year volatility
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.